Both in Pharmaceuticals
Prelude Therapeutics Incorporated vs BridgeBio Oncology Therapeutics
Over the past year PRLD returned +189.1% and BBOT returned −65.8%; their daily moves had a correlation of 0.18.
PRLD +189.1% BBOT −65.8%Growth of $1, one year, split-adjusted
| Metric | PRLD | BBOT |
|---|---|---|
| Price | $3.96 | $3.92 |
| Market cap | $316.0M | $314.3M |
| Today | +1.28% | +2.89% |
| 1 month | −27.6% | −55.1% |
| 6 months | +29.0% | −54.8% |
| Year to date | +36.6% | −68.7% |
| 1 year | +164.0% | −66.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −244.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 14.1× | — |
| Net cash | $151.8M | $225.7M |
| Dividend yield | — | — |
| Volatility (60d) | 84.1% | 89.1% |
| Short % of float | 21.3% | 14.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).